Randomised controlled trial: susceptibility‐guided therapy versus empiric bismuth quadruple therapy for first‐line <i>Helicobacter pylori</i> treatment

Abstract

Both susceptibility-guided and empiric therapies provided excellent eradication rates. Clinically, the choice would hinge on availability of susceptibility testing and/or a locally highly effective empiric therapy.